These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
442 related items for PubMed ID: 19427670
1. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma. Li Y, Meng G, Huang L, Guo QN. Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670 [Abstract] [Full Text] [Related]
4. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Vu TH, Hoffman AR. Nature; 1994 Oct 20; 371(6499):714-7. PubMed ID: 7935819 [Abstract] [Full Text] [Related]
5. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma. Eriksson T, Frisk T, Gray SG, von Schweinitz D, Pietsch T, Larsson C, Sandstedt B, Ekström TJ. Exp Cell Res; 2001 Oct 15; 270(1):88-95. PubMed ID: 11597130 [Abstract] [Full Text] [Related]
9. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population. Tang SH, Yang DH, Huang W, Zhou HK, Lu XH, Ye G. Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4171-7. PubMed ID: 16857788 [Abstract] [Full Text] [Related]
10. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Vu TH, Chuyen NV, Li T, Hoffman AR. Cancer Res; 2003 Apr 15; 63(8):1900-5. PubMed ID: 12702581 [Abstract] [Full Text] [Related]
11. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer]. Zhang FR, He XB, Yang YH, Xie W. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb 15; 20(1):31-4. PubMed ID: 12579496 [Abstract] [Full Text] [Related]
12. Chromatin structure and imprinting: developmental control of DNase-I sensitivity in the mouse insulin-like growth factor 2 gene. Feil R, Handel MA, Allen ND, Reik W. Dev Genet; 1995 Feb 15; 17(3):240-52. PubMed ID: 8565330 [Abstract] [Full Text] [Related]
13. Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development. Li X, Gray SG, Flam F, Pietsch T, Ekström TJ. Int J Dev Biol; 1998 Jul 15; 42(5):687-93. PubMed ID: 9712523 [Abstract] [Full Text] [Related]
14. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Gynecol Oncol; 2006 Dec 15; 103(3):990-5. PubMed ID: 16859738 [Abstract] [Full Text] [Related]
15. Hypomethylation trends in the intergenic region of the imprinted IGF2 and H19 genes in cloned cattle. Curchoe CL, Zhang S, Yang L, Page R, Tian XC. Anim Reprod Sci; 2009 Dec 15; 116(3-4):213-25. PubMed ID: 19282114 [Abstract] [Full Text] [Related]
16. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines. Ooasa T, Karasaki H, Kanda H, Nomura K, Kitagawa T, Ogawa K. Mol Carcinog; 1998 Dec 15; 23(4):248-53. PubMed ID: 9869454 [Abstract] [Full Text] [Related]
17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC. Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529 [Abstract] [Full Text] [Related]